AR038842A1 - Derivados de artemisinina (endoperoxidos) antiparasitarios - Google Patents

Derivados de artemisinina (endoperoxidos) antiparasitarios

Info

Publication number
AR038842A1
AR038842A1 ARP030100629A ARP030100629A AR038842A1 AR 038842 A1 AR038842 A1 AR 038842A1 AR P030100629 A ARP030100629 A AR P030100629A AR P030100629 A ARP030100629 A AR P030100629A AR 038842 A1 AR038842 A1 AR 038842A1
Authority
AR
Argentina
Prior art keywords
group
atom
optionally substituted
aryl
alkynyl
Prior art date
Application number
ARP030100629A
Other languages
English (en)
Spanish (es)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR038842A1 publication Critical patent/AR038842A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP030100629A 2002-03-08 2003-02-26 Derivados de artemisinina (endoperoxidos) antiparasitarios AR038842A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02005233 2002-03-08

Publications (1)

Publication Number Publication Date
AR038842A1 true AR038842A1 (es) 2005-01-26

Family

ID=27798779

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100629A AR038842A1 (es) 2002-03-08 2003-02-26 Derivados de artemisinina (endoperoxidos) antiparasitarios

Country Status (21)

Country Link
US (1) US20050119232A1 (enExample)
EP (1) EP1485389B1 (enExample)
JP (1) JP2005526073A (enExample)
KR (1) KR20040104493A (enExample)
CN (1) CN1649874A (enExample)
AR (1) AR038842A1 (enExample)
AT (1) ATE334987T1 (enExample)
AU (1) AU2003215584A1 (enExample)
BR (1) BR0308291A (enExample)
CA (1) CA2478600A1 (enExample)
DE (1) DE60307239D1 (enExample)
HR (1) HRP20040927A2 (enExample)
IL (1) IL163870A0 (enExample)
MX (1) MXPA04008638A (enExample)
NZ (1) NZ535084A (enExample)
PL (1) PL372341A1 (enExample)
RU (1) RU2004130284A (enExample)
TW (1) TW200400964A (enExample)
WO (1) WO2003076446A1 (enExample)
YU (1) YU79304A (enExample)
ZA (1) ZA200407102B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004027871B3 (de) * 2004-06-08 2006-03-16 Lanxess Deutschland Gmbh Verfahren zur Herstellung von 10α-[4'-(S,S-Dioxothiomorpholin-1'-yl)]-10-desoxo-10-dihydroartemisinin
EP1714967A1 (en) * 2005-04-22 2006-10-25 Bayer HealthCare AG Antiparasitic artemisinin derivatives
PT1940383E (pt) * 2005-10-20 2011-09-14 Epipharm Gmbh Tratamento e prevenção de sinais pigmentados benignos (nevos) utilizando artemisinina e os seus derivados
US8431611B2 (en) 2006-10-20 2013-04-30 Johns Hopkins University Artemisinin derivatives
WO2009062939A1 (en) * 2007-11-15 2009-05-22 Novartis Ag Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener
US8815942B2 (en) 2010-10-20 2014-08-26 The Royal Institution For The Advancement Of Learning/Mcgill University Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
CN102010422B (zh) * 2010-11-23 2014-11-26 沈阳药科大学 含有胍基的青蒿素类衍生物及其应用
US8232417B1 (en) 2010-12-01 2012-07-31 Bioderm Research Artemisinin derivatives with natural amino acids, peptides, and amino sugars for skin imperfections and infection in mammals
CN103183682B (zh) * 2011-12-31 2015-10-14 沈阳药科大学 C-10位脲基取代的青蒿素衍生物及其制备方法和用途
BR112014026158A2 (pt) * 2012-04-18 2017-06-27 Hadasit Med Res Service métodos e composições para o tratamento de infecções virais

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726203A (en) * 1993-07-19 1998-03-10 Li; Zelin Qinghaosu derivatives against AIDS
EP0974594A1 (en) * 1998-07-14 2000-01-26 The Hong Kong University of Science & Technology Artemisinin derivatives as anti-infective agent
BR9912810A (pt) * 1998-07-14 2001-05-02 Bayer Ag Derivados artemisinina (endoperóxidos) antiparasìticos

Also Published As

Publication number Publication date
BR0308291A (pt) 2005-01-11
WO2003076446A1 (en) 2003-09-18
WO2003076446A8 (en) 2004-10-07
TW200400964A (en) 2004-01-16
AU2003215584A1 (en) 2003-09-22
ATE334987T1 (de) 2006-08-15
RU2004130284A (ru) 2005-05-10
IL163870A0 (en) 2005-12-18
JP2005526073A (ja) 2005-09-02
US20050119232A1 (en) 2005-06-02
HRP20040927A2 (en) 2005-06-30
CN1649874A (zh) 2005-08-03
KR20040104493A (ko) 2004-12-10
EP1485389B1 (en) 2006-08-02
MXPA04008638A (es) 2005-04-19
PL372341A1 (en) 2005-07-11
CA2478600A1 (en) 2003-09-18
DE60307239D1 (de) 2006-09-14
ZA200407102B (en) 2005-09-06
NZ535084A (en) 2006-05-26
YU79304A (sh) 2006-08-17
EP1485389A1 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR041066A1 (es) 2,5-dioxoimidazolidin-4-il-acetamidas y analogos como inhibidores de la metaloproteinasa mmp12
AR043508A1 (es) 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores
AR085960A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
AR036586A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparacion, su utilizacion como medicamentos y las formulaciones farmaceuticas que las contienen
CO5600998A2 (es) Fluoropirrolidinas como inhibidores de dipeptidil peptidasa
AR043434A1 (es) Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4. composiciones farmaceuticas y usos
PE20240017A1 (es) Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR038843A1 (es) Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias
AR081577A1 (es) Derivados de aminopirimidina como moduladores de la lrrk2
AR043199A1 (es) Componentes heterociclicos utiles para el tratamiento de enfermedades inflamatorias y alergicas, proceso para su operacion y composicion farmaceutica que contiene dichos componentes
AR073138A1 (es) Derivados de dioxa-biciclo (3.2.1) octano- 2,3,4-triol
CO5580746A2 (es) Derivados de fenil-piperazina como inhibidores de la reabsorcion de la serotonina
AR043014A1 (es) Amino-1,3,5-triazinas n-sustituidas con radicales biciclicos quirales, procedimiento para su preparacion, composiciones de las mismas, y su uso como herbicidas y reguladores del crecimiento de las plantas
BRPI0921701B8 (pt) Cefarosporina tendo um grupo catecol, seu uso e composição farmacêutica que a compreende
AR079327A1 (es) Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida
AR045595A1 (es) Composiciones utiles como inhibidores de proteinas quinasas
AR086319A1 (es) Compuestos heterociclicos fusionados como moduladores de canal ionico
AR054214A1 (es) Compuestos derivados de 1, 1 - dioxotiadiazina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de la infeccion por el virus de la hepatitis c.
AR074608A1 (es) Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas
AR044402A1 (es) Compuestos heterociclicos y su uso como inmunodepresores. composiciones farmaceuticas que los contienen.
AR065927A1 (es) Derivados de 5,6-dihidro-1h-piridin-2-ona
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
ECSP088731A (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen

Legal Events

Date Code Title Description
FB Suspension of granting procedure